Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples